Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Salgia

Showing results (301-310 of 528) with videos related to

Pageof 53
Sort By:
JCO Precision Oncology|September 1, 2023
Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the BlockJason Liu, Arya Amini, Ameish Govindarajan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2002
Gemcitabine-induced radiation recallMelenda D Jeter, Pasi A Jänne, Sarah Brooks, et al.
The Journal of Biological Chemistry|December 26, 2001
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activationKlaus Podar, Yu-Tzu Tai, Boris K Lin, et al.
Oncotarget|June 12, 2020
The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapyCarlos Galvez, Saya Jacob, Brian S Finkelman, et al.
European Urology|April 25, 2018
Responses to Alectinib in ALK-rearranged Papillary Renal Cell CarcinomaSumanta K Pal, Paulo Bergerot, Nazli Dizman, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase InhibitionAdam Rock, Isa Mambetsariev, Siddhika Pareek, et al.
Biochemical Pharmacology|August 19, 2024
Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potentialPankaj Garg, Sravani K Ramisetty, Ayalur Raghu Subbalakshmi, et al.
Oncotarget|October 6, 2017
Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogrammingHaymanti Bhanot, Ellen L Weisberg, Mamatha M Reddy, et al.
Cancer Discovery|March 6, 2012
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrenceDaniel V T Catenacci, Les Henderson, Shu-Yuan Xiao, et al.
The Journal of Biological Chemistry|March 29, 2002
A fragment of paxillin binds the alpha 4 integrin cytoplasmic domain (tail) and selectively inhibits alpha 4-mediated cell migrationShouchun Liu, William B Kiosses, David M Rose, et al.
Pageof 53

Showing results (301-310 of 528) with videos related to

Sort By:
Pageof 53
JCO Precision Oncology|September 1, 2023
Targeted Therapies in Early-Stage Resectable Non-Small-Cell Lung Cancer: New Kids on the BlockJason Liu, Arya Amini, Ameish Govindarajan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 23, 2002
Gemcitabine-induced radiation recallMelenda D Jeter, Pasi A Jänne, Sarah Brooks, et al.
The Journal of Biological Chemistry|December 26, 2001
Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activationKlaus Podar, Yu-Tzu Tai, Boris K Lin, et al.
Oncotarget|June 12, 2020
The role of EGFR mutations in predicting recurrence in early and locally advanced lung adenocarcinoma following definitive therapyCarlos Galvez, Saya Jacob, Brian S Finkelman, et al.
European Urology|April 25, 2018
Responses to Alectinib in ALK-rearranged Papillary Renal Cell CarcinomaSumanta K Pal, Paulo Bergerot, Nazli Dizman, et al.
Current Oncology (Toronto, Ont.)|October 28, 2025
Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase InhibitionAdam Rock, Isa Mambetsariev, Siddhika Pareek, et al.
Biochemical Pharmacology|August 19, 2024
Gynecological cancer tumor Microenvironment: Unveiling cellular complexity and therapeutic potentialPankaj Garg, Sravani K Ramisetty, Ayalur Raghu Subbalakshmi, et al.
Oncotarget|October 6, 2017
Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogrammingHaymanti Bhanot, Ellen L Weisberg, Mamatha M Reddy, et al.
Cancer Discovery|March 6, 2012
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrenceDaniel V T Catenacci, Les Henderson, Shu-Yuan Xiao, et al.
The Journal of Biological Chemistry|March 29, 2002
A fragment of paxillin binds the alpha 4 integrin cytoplasmic domain (tail) and selectively inhibits alpha 4-mediated cell migrationShouchun Liu, William B Kiosses, David M Rose, et al.
Pageof 53